Cite
A Modified Basophil Activation Test for the Clinical Management of Immediate Hypersensitivity Reactions to Paclitaxel: A Proof-of-Concept Study.
MLA
La Sorda, Marilena, et al. “A Modified Basophil Activation Test for the Clinical Management of Immediate Hypersensitivity Reactions to Paclitaxel: A Proof-of-Concept Study.” Cancers, vol. 15, no. 24, Dec. 2023, p. 5818. EBSCOhost, https://doi.org/10.3390/cancers15245818.
APA
La Sorda, M., Fossati, M., Graffeo, R., Ferraironi, M., De Rosa, M. C., Buzzonetti, A., Righino, B., Zampetti, N., Fattorossi, A., Nucera, E., Aruanno, A., Ferrandina, G., Apostol, A. I., Buonomo, A., Scambia, G., Sanguinetti, M., & Battaglia, A. (2023). A Modified Basophil Activation Test for the Clinical Management of Immediate Hypersensitivity Reactions to Paclitaxel: A Proof-of-Concept Study. Cancers, 15(24), 5818. https://doi.org/10.3390/cancers15245818
Chicago
La Sorda, Marilena, Marco Fossati, Rosalia Graffeo, Manuela Ferraironi, Maria Cristina De Rosa, Alexia Buzzonetti, Benedetta Righino, et al. 2023. “A Modified Basophil Activation Test for the Clinical Management of Immediate Hypersensitivity Reactions to Paclitaxel: A Proof-of-Concept Study.” Cancers 15 (24): 5818. doi:10.3390/cancers15245818.